Patient Information Leaflet: Information for the User
Colchicine Strides 0.5 mg Tablets EFG
Important Warning! Do not exceed the recommended dose.Overdose, including that resulting from ignoring interactions, can lead to very painful and irreversible poisoning with a fatal outcome. Consult sections2, 3, and 4 of this leaflet. The medication should be kept out of the reach of others before and after use. |
Read the entire leaflet carefully before starting to use this medication because it contains important information for you.
Contents of the Leaflet
Colchicine Stridescontains the active ingredient colchicine. It belongs to the group of anti-gout medications and is used to prevent or treat gout attacks.
Gout attacks in adults
Colchicine Strides is indicated in adults for the short-term treatment of acute gout, known as gout attacks, and to prevent recurrent gout.
The concentration of uric acid in the blood increases when the patient has gout. This can cause the formation of uric acid crystals in the synovial fluid. Colchicine inhibits the resulting inflammation.
Familial Mediterranean Fever
Colchicine Strides is indicated in patients with Familial Mediterranean Fever to prevent febrile episodes and amyloidosis (abnormal accumulation of proteins in tissues and organs).
You should consult your doctor if your condition worsens or does not improve after taking this medication.
Do not take Colchicine Strides
Warnings and precautions
There is a slight difference between an effective dose of colchicine and a dose that can cause symptoms of pharmacological poisoning. This means that even a slightly higher dose than the recommended one can cause signs of pharmacological poisoning. If you experience symptoms such as nausea, vomiting, stomach pain, or diarrhea, stop taking colchicine and contact your doctor immediately (see also section 4).
Consult your doctor or pharmacist before starting to take this medication if any of the following situations apply to you or have applied in the past:
Colchicine can cause severe deterioration in bone marrow function, which can lead to a decrease in certain white blood cells (agranulocytosis), platelet deficiency (thrombocytopenia), a decrease in red blood cells, and pigment due to the lack of production of red blood cells (aplastic anemia). Regular blood tests should be performed to monitor any changes
If you experience symptoms such as fever, inflammation in the mouth, sore throat, prolonged bleeding, bruising, or skin changes, stop taking this medication and contact your doctor immediately. These may be signs of a severe blood disorder, and your doctor may want to perform a blood test immediately (see also section 4).
Prolonged use of colchicine can cause a vitamin B12 deficiency.
Children and adolescents up to 18 years
In children, colchicine should only be prescribed under the strict supervision of a specialist doctor. There are no data available on the effect of long-term use of colchicine in children.
Other medications and Colchicine Strides
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Consult your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Contact your doctor if you take Colchicine Stridesin addition to other medications that may reduce the number of blood cells (which can affect the blood count) or that may have a negative impact on liver and kidney function.
If you take Colchicine Stridessimultaneously with any of the following medications, the likelihood of experiencing side effects due to colchicine poisoning increases, which can be very severe. You should inform your doctor or pharmacist if you are taking:
Also, inform your doctor or pharmacist if you take any of the following medications:
Taking Colchicine Strides with food and drinks
You should not drink grapefruit juice during treatment with colchicine.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Women of childbearing age
Gout treatment
Women who may become pregnant should use effective contraceptive methods during treatment and for at least 3 months after the end of treatment for gout with Colchicine Strides. If you become pregnant during this period, you should consult your doctor about the risks of congenital anomalies.
Pregnancy
Gout treatment
You should not use Colchicine Strides if you are pregnant or plan to become pregnant. If you become pregnant during treatment with Colchicine Strides or within 3 months after stopping treatment, you should consult your doctor about the risks of congenital anomalies.
Familial Mediterranean Fever treatment:
Since the course of untreated Familial Mediterranean Fever can also have a negative effect on pregnancy, the risks and benefits of treatment with Colchicine Strides during pregnancy should be considered if clinically necessary.
Breastfeeding
The active ingredient colchicine is excreted in breast milk.
Colchicine Strides should not be used for the treatment of gout in breastfeeding women.
In breastfeeding mothers with Familial Mediterranean Fever, a decision should be made to either stop breastfeeding or discontinue/not start treatment with colchicine, taking into account the benefit of breastfeeding for the baby and the benefit of treatment for the woman.
Fertility
Gout treatment
Male patients' partners should not become pregnant during treatment and for at least 6 months after stopping treatment with colchicine. If the partner becomes pregnant during this time, you should consult your doctor about the risks of congenital anomalies.
Male patients should not father children during treatment with colchicine and for at least 6 months after stopping treatment. If, despite this, a pregnancy occurs during this time, you should consult your doctor about the risks of congenital anomalies.
Familial Mediterranean Fever treatment:
Since the course of untreated Familial Mediterranean Fever can also cause infertility, the risks and benefits of using Colchicine Strides should be weighed, and treatment should only be considered if clinically necessary.
Driving and using machines
There are no data available on the influence of colchicine on the ability to drive and use machines. However, it may cause drowsiness and dizziness.
Colchicine Strides contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Colchicine Strides contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Always follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Gout treatment
Treatment of an acute gout attack:
The recommended dose is 0.5 mg two or three times a day. Your doctor may prescribe an additional dose of 1 mg for the first day of treatment. Stop treatment if you experience gastrointestinal symptoms or if you have not had any effect after 2 or 3 days.
You should not take more than 6 mg of Colchicine Strides during a treatment cycle.
After completing a treatment cycle with Colchicine Strides (or with any other medication containing colchicine), do not start a new cycle until at least 3 days have passed.
Prevention of a gout attack:
The recommended dose is 0.5 mg or 1 mg per day, administered at night. Your doctor will indicate how long you should take Colchicine Strides.
If you have liver or kidney disease:
If you have liver or kidney dysfunction, the recommended dose is 0.5 mg of colchicine per day, and your doctor should closely monitor you. If you have severe liver or kidney failure, do not use this medication (see section 2).
Children and adolescents
Colchicine Strides is not indicated for the treatment of gout in children and adolescents.
Treatment of Familial Mediterranean Fever
The recommended dose is 1 mg or 3 mg per day. The daily dose can be administered as a single dose or divided into two daily doses (in the case of doses higher than 1 mg/day).
If you do not improve, your doctor may gradually increase the dose of colchicine up to a maximum dose of 3 mg per day. In the case of a reduction in the dose of colchicine, your doctor should monitor you to evaluate possible side effects.
Use in children and adolescents up to 18 years
In children with Familial Mediterranean Fever, the recommended dose is based on age.
In children with amyloid nephropathy, the dose can be increased to 2 mg per day.
Dose in patients with liver or kidney failure
In case of liver or kidney failure, it is recommended to administer half the dose. If you have severe liver or kidney failure, do not use this medication (see section 2).
If you take more Colchicine Strides than you should
If you take more tablets of Colchicine Strides than you should, or if a child accidentally takes some tablets, there is a risk of poisoning. You should contact your doctor, pharmacist, or the emergency department of the nearest hospital immediately.
In case of overdose or accidental ingestion, contact your doctor or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken
Signs of poisoning:
If you forget to take Colchicine Strides
Do not take a double dose to make up for forgotten doses.
If you forget to take a dose, you should take it as soon as possible.
If it is almost time for your next dose, do not take the missed dose, just take the next dose and continue with the administration schedule.
In case of doubt, always consult your doctor or pharmacist.
If you stop taking Colchicine Strides
If you stop taking this medication suddenly, you may experience the symptoms you had before starting treatment again. Consult your doctor if you are thinking of stopping colchicine.
If you have any questions about this medication, consult your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Stop taking Colchicine Strides and contact your doctor or go to the emergency department of the nearest hospital immediately if you experience any of the following side effects:
Additionally, the following side effects are known:
Uncommon (may affect 1 in 100 patients):
Rare (may affect 1 in 1,000 patients).
Very rare (may affect 1 in 10,000 patients):
Frequency not known (cannot be estimated from available data):
•Vitamin B12 deficiency.
Children and adolescents up to 18 years
There are no data available on the effect of long-term use of colchicine in children and adolescents up to 18 years.
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Store the blister in the outer packaging to protect it from light.
Do not use this medicine after the expiry date that appears on the packaging and on the blister after «EXP». The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in your pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Colchicine Strides
Appearance of Colchicine Strides and Package Contents
Colchicine Strides 0.5 mg tablets are round, white tablets engraved with C5 on one face and smooth on the other face.
Each tablet has a diameter of approximately 6.4 mm.
Colchicine Strides is available in packs with PVC-aluminum blisters containing 12, 30, or 100 tablets.
Only some pack sizes may be marketed.
Marketing Authorization Holder
Strides Pharma (Cyprus) Limited
Themistokli Dervi, 3
Julia House, 1st Floor
Nicosia 1066
Cyprus
Manufacturer
Fairmed Healthcare GmbH
Maria-Goeppert-Straße 3
23562 Lübeck
Germany
Country | Marketing Authorization Name |
Denmark | Colchicin Strides 0.5 mg tablets |
Germany | Colchicin STRIDES 0.5 mg tablets |
Netherlands | Colchicine Strides 0.5 mg tablets |
Spain | Colchicina STRIDES 0.5 mg tablets EFG |
Sweden | Kolkicin Strides 500 microgram tablets |
Date of the last revision of this leaflet:06/2022.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/